These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35331319)

  • 1. Fragment-based virtual screening discovers potential new Plasmodium PI4KIIIβ ligands.
    Ibezim A; Madukaife MS; Osigwe SC; Engel N; Karuppasamy R; Ntie-Kang F
    BMC Chem; 2022 Mar; 16(1):19. PubMed ID: 35331319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for Inhibitor Potency and Selectivity of
    Fienberg S; Eyermann CJ; Arendse LB; Basarab GS; McPhail JA; Burke JE; Chibale K
    ACS Infect Dis; 2020 Nov; 6(11):3048-3063. PubMed ID: 32966036
    [No Abstract]   [Full Text] [Related]  

  • 3. Fragment-based virtual screening identifies novel leads against Plasmepsin IX (PlmIX) of
    Almuqdadi HTA; Kifayat S; Anwer R; Alrehaili J; Abid M
    Front Pharmacol; 2024; 15():1387629. PubMed ID: 38846093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
    Ibrahim MAA; Abdelrahman AHM; Hassan AMA
    Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel phosphatidylinositol 4-kinases III beta (PI4KIIIβ) inhibitors discovered by virtual screening using free energy models.
    Colodette NM; Franco LS; Maia RC; Fokoue HH; Sant'Anna CMR; Barreiro EJ
    J Comput Aided Mol Des; 2020 Oct; 34(10):1091-1103. PubMed ID: 32601839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 6'-chloro-N-methyl-5'-(phenylsulfonamido)-[3,3'-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium.
    Liang X; Jiang Z; Huang Z; Li F; Chen C; Hu C; Wang W; Hu Z; Liu Q; Wang B; Wang L; Qi Z; Liu J; Jiang L; Liu Q
    Eur J Med Chem; 2020 Feb; 188():112012. PubMed ID: 31911293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening against multiple Plasmodium falciparum kinases reveals antimalarial compounds.
    Godara P; Reddy KS; Sahu W; Naik B; Srivastava V; Das R; Mahor A; Kumar P; Giri R; Anirudh J; Tak H; Banavath HN; Bhatt TK; Goyal AK; Prusty D
    Mol Divers; 2024 Dec; 28(6):3661-3681. PubMed ID: 38127294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling and virtual screening for inhibitors of lipid kinase PI(4)K from Plasmodium.
    Ren JX; Gao NN; Cao XS; Hu QA; Xie Y
    Biomed Pharmacother; 2016 Oct; 83():798-808. PubMed ID: 27490781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold-based Screening and Molecular Dynamics Simulation Study to Identify Two Structurally Related Phenolic Compounds as Potent MMP1 Inhibitors.
    Patra S; Saravanan P; Das B; Subramanian V; Patra S
    Comb Chem High Throughput Screen; 2020; 23(8):757-774. PubMed ID: 32342802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel inhibitors targeting Plasmodium knowlesi dihydrofolate reductase using molecular docking and molecular dynamics simulation.
    Yadav MK; Tripathi MK; Yadav S
    Microb Pathog; 2021 Dec; 161(Pt A):105214. PubMed ID: 34592368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Amidated 3,6-Diphenylated Imidazopyridazines with Potent Antiplasmodium Activity Are Dual Inhibitors of
    Cheuka PM; Centani L; Arendse LB; Fienberg S; Wambua L; Renga SS; Dziwornu GA; Kumar M; Lawrence N; Taylor D; Wittlin S; Coertzen D; Reader J; van der Watt M; Birkholtz LM; Chibale K
    ACS Infect Dis; 2021 Jan; 7(1):34-46. PubMed ID: 33319990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study.
    Boateng RA; Tastan Bishop Ö; Musyoka TM
    Malar J; 2020 Nov; 19(1):442. PubMed ID: 33256744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-based virtual screening approach and molecular dynamics simulation studies for identification of BACE1 inhibitor leads.
    Manoharan P; Ghoshal N
    J Biomol Struct Dyn; 2018 May; 36(7):1878-1892. PubMed ID: 28617091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Target Chemometric Modelling, Fragment Analysis and Virtual Screening with ERK Inhibitors as Potential Anticancer Agents.
    Halder AK; Giri AK; Cordeiro MNDS
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31671605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoinformatics based elucidation and designing of potential inhibitors against Plasmodium falciparum to target importin α/β mediated nuclear importation.
    Oany AR; Pervin T; Moni MA
    Infect Genet Evol; 2021 Mar; 88():104699. PubMed ID: 33385575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.